Sartorius Stedim Biotech's total assets for Q3 2026 were €8.04B, an increase of 1.53% from the previous quarter. DE:56S1 total liabilities were €3.65B for the fiscal quarter, a -0.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.